Mucosal vaccines, sterilizing immunity, and the future of SARS-CoV-2 virulence

D Focosi, F Maggi, A Casadevall - Viruses, 2022 - mdpi.com
Sterilizing immunity after vaccination is desirable to prevent the spread of infection from
vaccinees, which can be especially dangerous in hospital settings while managing frail …

Analysis of anti-SARS-CoV-2 Omicron-neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources

DJ Sullivan, M Franchini, MJ Joyner… - Nature …, 2022 - nature.com
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …

SARS-CoV-2 variants of concern and vaccine escape, from Alpha to Omicron and beyond

SWX Ong, T Chia, BE Young - Expert Review of Respiratory …, 2022 - Taylor & Francis
1. Background More than nine billion Coronavirus Disease-2019 (COVID-19) vaccine doses
were administered worldwide in 2021, and~ 58% of the global population has received at …

[PDF][PDF] Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma sources

D Focosi, M Franchini, MJ Joyner, A Casadevall… - medRxiv, 2021 - scienceopen.com
Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma sources
Page 1 1 Analysis of anti-Omicron neutralizing antibody titers in different convalescent plasma …

Systematic analysis of SARS-CoV-2 Omicron subvariants' impact on B and T cell epitopes

R Al Khalaf, A Bernasconi, P Pinoli - Plos one, 2024 - journals.plos.org
Introduction Epitopes are specific structures in antigens that are recognized by the immune
system. They are widely used in the context of immunology-related applications, such as …

[HTML][HTML] Analysis of anti-Omicron neutralizing antibody titers in different vaccinated and unvaccinated convalescent plasma sources

DJ Sullivan, M Franchini, MJ Joyner, A Casadevall… - medRxiv, 2022 - ncbi.nlm.nih.gov
The latest SARS-CoV-2 variant of concern Omicron, with its immune escape from
therapeutic anti-Spike monoclonal antibodies and WA-1 vaccine-elicited sera, demonstrates …

Predicted symptomatic effectiveness of Pfizer-BioNTech BNT162b2 vaccine against omicron variant of SARS-CoV-2

O Volkov - MedRxiv, 2021 - medrxiv.org
This paper presents predictions of the symptomatic effectiveness of the Pfizer-BioNTech
BNT162b2 (Comirnaty) vaccine against Omicron B. 1.1. 529, the latest SARS-CoV-2 variant …

[PDF][PDF] World Facing the latest variant of Concern---------Omicron

MM Javaid, A Fazal, M Hyder, FA Chaudhary… - Ethiopian Journal of …, 2022 - ajol.info
TO THE EDITOR: On November 24, 2021, from the Republic of South Africa,“B. 1.1. 529”
variant was revealed and conveyed to WHO. The first confirmed and verified B. 1.1. 529 …